Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 28772306.
- Also identified by DOI 10.1001/jamaoncol.2017.1358 and PMC identifier 5824279.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This interim analysis of an ongoing randomized clinical trial presents preliminary findings regarding use of whole-body magnetic resonance imaging for cancer surveillance of <i>TP53</i> mutation carriers.
Medical subject headings
- Adenocarcinoma of Lung
- Germ-Line Mutation
- Li-Fraumeni Syndrome
- Lung Neoplasms
- Tumor Suppressor Protein p53